LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_003000.3:c.73-29del
SDHB
· NP_002991.2:p.?
· NM_003000.3
GRCh37: chr1:17371411 GA>G
·
GRCh38: chr1:17044916 GA>G
Gene:
SDHB
Transcript:
NM_003000.3
Final call
VUS
Variant details
Gene
SDHB
Transcript
NM_003000.3
Protein
NP_002991.2:p.?
gnomAD AF
0.000786436882320673 (v4.1)
ClinVar
Likely benign
OncoKB
Classification rationale
Interpretation summary
Generated evidence synthesis
1
No ACMG/AMP criteria were met; with no pathogenic or benign combination threshold satisfied, the variant is classified as a variant of uncertain significance (VUS).
Final determination:
With no applied criteria, the generic ACMG/AMP 2015 fallback rules classify the variant as VUS because no pathogenic, likely pathogenic, benign, or likely benign combination threshold is met.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Not met | Not met: intronic one-base deletion with no predicted protein change and SpliceAI max delta 0.002, not a null or splice-disrupting variant. |
cspec
pvs1_generic_framework
pvs1_variant_assessment
spliceai
PMID:25741868
|
| PS1 | N/A | Not applicable: intronic variant with no predicted protein change, so no same-residue amino-acid comparison is possible. |
cspec
|
| PS2 | Not assessed | Not assessed: no parental genotype or pedigree evidence establishes a de novo origin in the proband. |
cspec
clinvar
|
| PS3 | Not assessed | Not assessed: no validated variant-specific functional assay evidence was available. |
cspec
PMID:25741868
|
| PS4 | Not assessed | Not assessed: no case-control or enrichment evidence for this variant was available. |
cspec
|
| PM1 | N/A | Not applicable: intronic variant with no protein residue to assess against critical domains or hotspots. |
cspec
|
| PM2 | Not met | Not met: gnomAD v4.1 reports 1253 alternate alleles with two homozygotes, so the variant is not absent from controls. |
gnomad_v2
gnomad_v4
gnomad_canada
|
| PM3 | N/A | Not applicable: SDHB disease is autosomal dominant here, and PM3 requires recessive inheritance. |
cspec
|
| PM4 | Not met | Not met: intronic deletion with no predicted protein-length change, not an in-frame coding indel. |
cspec
spliceai
PMID:25741868
|
| PM5 | N/A | Not applicable: no predicted amino-acid change, so no pathogenic missense at the same residue to compare. |
cspec
|
| PM6 | Not assessed | Not assessed: no case documentation of presumed de novo occurrence with incomplete parental testing. |
cspec
clinvar
|
| PP1 | Not assessed | Not assessed: no family or segregation data were available for this variant. |
cspec
|
| PP2 | N/A | Not applicable: not a missense variant, which PP2 requires. |
cspec
|
| PP3 | Not met | Not met: SpliceAI max delta 0.002 shows no predicted splice effect. |
spliceai
|
| PP4 | Not assessed | Not assessed: no proband or carrier phenotype was provided to assess specificity. |
cspec
|
| PP5 | Not met | Not met: ClinVar has no expert-panel pathogenic or likely pathogenic assertion for this exact variant. |
clinvar
|
| BA1 | Not met | Not met: gnomAD v4.1 maximum population allele frequency 0.00098 (0.098%) is below the 1% BA1 threshold. |
cspec
gnomad_v2
gnomad_v4
gnomad_canada
|
| BS1 | Not met | Not met: highest observed frequency 0.098% (gnomAD v4.1 European non-Finnish) is below the 0.3% BS1 threshold. |
cspec
gnomad_v2
gnomad_v4
gnomad_canada
|
| BS2 | Not assessed | Not assessed: two gnomAD homozygotes are reported, but their unaffected status could not be confirmed. |
gnomad_v4
|
| BS3 | Not assessed | Not assessed: no functional study demonstrating preserved SDHB function was available. |
cspec
PMID:25741868
|
| BS4 | Not assessed | Not assessed: no phenotype-confirmed non-segregation analysis was available. |
cspec
|
| BP1 | N/A | Not applicable: not a missense variant; BP1 applies only to missense changes. |
cspec
|
| BP2 | Not assessed | Not assessed: no genotype or phase data establish an allelic relationship with a pathogenic variant. |
cspec
|
| BP3 | Not met | Not met: no in-frame coding repeat-region indel is established for this intronic deletion. |
cspec
spliceai
PMID:25741868
|
| BP4 | Not assessed | Not assessed: SpliceAI max delta 0.002 is low, but no verified calibration supports a benign call from this single predictor. |
spliceai
cspec
|
| BP5 | Not assessed | Not assessed: no evidence that another molecular diagnosis explains the phenotype. |
cspec
|
| BP6 | Not met | Not met: ClinVar has no expert-panel benign or likely benign assertion for this exact variant. |
clinvar
|
| BP7 | N/A | Not applicable: intronic deletion, not a synonymous coding variant as BP7 requires. |
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.